 | Up a level |
Bohlius, Julia; Bohlius, J; Schmidlin, K; Costagliola, D; Fätkenheuer, G; May, M; Caro-Murillo, AM; Mocroft, A; Bonnet, F; Clifford, G; Karafoulidou, A; Miro, JM; Lundgren, J; Chene, G; Egger, Matthias (2009). Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study. Antiviral therapy, 14(8), pp. 1065-74. London: International Medical Press 10.3851/IMP1462
May, M; Sterne, JA; Sabin, C; Costagliola, D; Justice, AC; Thiébaut, R; Gill, J; Phillips, A; Reiss, P; Hogg, R; Ledergerber, B; D'Arminio Monforte, A; Schmeisser, N; Staszewski, S; Antiretroviral, Therapy (ART) Cohort Collaboration (2007). Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS, 21(9), pp. 1185-1197. Hagerstown, Md.: Lippincott Williams & Wilkins
Sterne, JA; May, M; Bucher, HC; Ledergerber, B; Furrer, H; Cavassini, M; Bernasconi, E; Hirschel, B; Egger, M; Swiss, HIV Cohort (2007). HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy. Journal of internal medicine, 261(3), pp. 255-67. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2796.2006.01761.x
Antiretroviral, Therapy in Low-Income Countries Collaboration of the Internation; Cohort Collaboration, ART; Brinkhof, MW; Egger, M; Boulle, A; May, M; Hosseinipour, M; Sprinz, E; Braitstein, P; Dabis, F; Reiss, P; Bangsberg, DR; Rickenbach, M; Miro, JM; Myer, L; Mocroft, A; Nash, D; Keiser, O; Pascoe, M; van der Borght, S; ... (2007). Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clinical infectious diseases, 45(11), pp. 1518-21. Cary, N.C.: Oxford University Press 10.1086/522986
The, Antiretroviral Therapy (ART) Cohort Collaboration; Sterne, JA; May, M; Sabin, C; Phillips, A; Costagniola, D; Chêne, G; Justice, AC; De Wolf, F; Hogg, R; Battegay, M; D'Arminio Monforte, A; Fätkenheuer, G; Staszewski, S; Gill, J; Egger, M (2007). Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy. Journal of acquired immune deficiency syndromes JAIDS, 46(5), pp. 607-615. Philadelphia, Pa.: Lippincott Williams & Wilkins
Braitstein, P; Brinkhof, MW; Dabis, F; Schechter, M; Boulle, A; Miotti, P; Wood, R; Laurent, C; Sprinz, E; Seyler, C; Bangsberg, DR; Balestre, E; Sterne, JA; May, M; Egger, M; Antiretroviral, Therapy in Lower Income Countries (ART-LINC) Collaboration; Cohort Collaboration (ART-CC) groups, ART (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet, 367(9513), pp. 817-824. London: Elsevier 10.1016/S0140-6736(06)69886-3
